mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.35 |
0.1 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.1 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |